Gilead Sciences Inc. (GILD)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
11-Mar-24 8:59 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 10-Mar-24Payment of Exercise 4,505$75.12$338,416.00(3%)
139.49K to 134.98K
11-Mar-24 9:14 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 10-Mar-24Payment of Exercise 4,803$75.12$360,801.00(5%)
103.11K to 98.3K
11-Mar-24 9:11 PM
View: 
O'Day Daniel Patrick
Chairman & CEO
Director
Gilead Sciences Inc. (GILD) 10-Mar-24Payment of Exercise 13,782$75.12$1,035,300.00(3%)
498.63K to 484.85K
11-Mar-24 8:59 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 10-Mar-24Option Exercise 9,732----8%
129.76K to 139.49K
11-Mar-24 9:03 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 10-Mar-24Payment of Exercise 4,559$75.12$342,472.00(4%)
122.99K to 118.43K
12-Mar-24 4:19 PM
View: 
Telman Deborah H
EVP, Corporate Affairs & GC
Gilead Sciences Inc. (GILD) 10-Mar-24Payment of Exercise 846$75.12$63,551.50(6%)
14.6K to 13.76K
11-Mar-24 9:14 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 10-Mar-24Option Exercise 10,401----11%
92.71K to 103.11K
12-Mar-24 3:57 PM
View: 
Patterson Sandra
SVP, Controllership
Gilead Sciences Inc. (GILD) 10-Mar-24Payment of Exercise 790$75.12$59,344.80(2%)
33.42K to 32.63K
11-Mar-24 9:11 PM
View: 
O'Day Daniel Patrick
Chairman & CEO
Director
Gilead Sciences Inc. (GILD) 10-Mar-24Option Exercise 29,940----6%
468.69K to 498.63K
11-Mar-24 9:03 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 10-Mar-24Option Exercise 9,844----9%
113.15K to 122.99K
12-Mar-24 4:19 PM
View: 
Telman Deborah H
EVP, Corporate Affairs & GC
Gilead Sciences Inc. (GILD) 10-Mar-24Option Exercise 2,555----21%
12.05K to 14.6K
12-Mar-24 3:57 PM
View: 
Patterson Sandra
SVP, Controllership
Gilead Sciences Inc. (GILD) 10-Mar-24Option Exercise 2,682----9%
30.74K to 33.42K
29-Feb-24 6:35 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 29-Feb-24Market Sale (Planned) 8,230$72.74$598,624.00(8%)
100.94K to 92.71K
< 1%
29-Feb-24 6:35 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 28-Feb-24Market Sale (Planned) 2,000$73.18$146,360.00(2%)
102.94K to 100.94K
1%
06-Feb-24 6:01 PM
View: 
Love Ted W
Director
Gilead Sciences Inc. (GILD) 02-Feb-24Grant 512----100%
0 to 0.51K
02-Feb-24 2:11 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 31-Jan-24Payment of Exercise 23,410$78.26$1,832,070.00(15%)
152.85K to 129.44K
02-Feb-24 2:34 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 31-Jan-24Grant 74,055----120%
61.6K to 135.66K
02-Feb-24 2:19 PM
View: 
Telman Deborah H
EVP, Corporate Affairs & GC
Gilead Sciences Inc. (GILD) 31-Jan-24Grant 4,646----66%
7.08K to 11.73K
02-Feb-24 2:42 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 31-Jan-24Grant 76,853----155%
49.47K to 126.33K
02-Feb-24 1:40 PM
View: 
O'Day Daniel Patrick
Chairman & CEO
Director
Gilead Sciences Inc. (GILD) 31-Jan-24Grant 230,747----73%
317.28K to 548.02K
02-Feb-24 2:34 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 31-Jan-24Payment of Exercise 22,509$78.26$1,761,550.00(17%)
135.66K to 113.15K
02-Feb-24 2:42 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 31-Jan-24Payment of Exercise 23,709$78.26$1,855,470.00(19%)
126.33K to 102.62K
02-Feb-24 1:40 PM
View: 
O'Day Daniel Patrick
Chairman & CEO
Director
Gilead Sciences Inc. (GILD) 31-Jan-24Payment of Exercise 79,335$78.26$6,208,760.00(14%)
548.02K to 468.69K
02-Feb-24 2:11 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 31-Jan-24Grant 74,961----96%
77.89K to 152.85K
26-Jan-24 4:31 PM
View: 
Telman Deborah H
EVP, Corporate Affairs & GC
Gilead Sciences Inc. (GILD) 25-Jan-24Option Exercise 514----8%
6.76K to 7.28K
26-Jan-24 4:31 PM
View: 
Telman Deborah H
EVP, Corporate Affairs & GC
Gilead Sciences Inc. (GILD) 25-Jan-24Payment of Exercise 194$80.23$15,564.60(3%)
7.28K to 7.08K
17-Jan-24 6:01 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 16-Jan-24Private Sale (Planned) 5,000$85.78$428,900.00(5%)
106.53K to 101.53K
10-Jan-24 3:58 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 09-Jan-24Private Sale (Planned) 8,242$85.23$702,466.00(9%)
90.97K to 82.73K
11-Dec-23 7:10 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 10-Dec-23Option Exercise 2,779----4%
70.13K to 72.91K
11-Dec-23 7:08 PM
View: 
Patterson Sandra
SVP, Controllership
Gilead Sciences Inc. (GILD) 10-Dec-23Option Exercise 518----2%
30.12K to 30.64K
11-Dec-23 7:04 PM
View: 
O'Day Daniel Patrick
Chairman & CEO
Director
Gilead Sciences Inc. (GILD) 10-Dec-23Option Exercise 7,347----2%
383.69K to 391.03K
11-Dec-23 7:00 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 10-Dec-23Option Exercise 2,617----2%
105.11K to 107.73K
11-Dec-23 7:00 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 10-Dec-23Payment of Exercise 1,194$79.02$94,349.90(1%)
107.73K to 106.53K
11-Dec-23 7:15 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 10-Dec-23Payment of Exercise 1,247$79.02$98,537.90(1%)
92.22K to 90.97K
11-Dec-23 7:10 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 10-Dec-23Payment of Exercise 1,269$79.02$100,276.00(2%)
72.91K to 71.64K
11-Dec-23 7:08 PM
View: 
Patterson Sandra
SVP, Controllership
Gilead Sciences Inc. (GILD) 10-Dec-23Payment of Exercise 222$79.02$17,542.40(< 1%)
30.64K to 30.42K
11-Dec-23 7:04 PM
View: 
O'Day Daniel Patrick
Chairman & CEO
Director
Gilead Sciences Inc. (GILD) 10-Dec-23Payment of Exercise 3,341$79.02$264,006.00(< 1%)
391.03K to 387.69K
11-Dec-23 7:15 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 10-Dec-23Option Exercise 2,730----3%
89.49K to 92.22K
13-Nov-23 6:21 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 10-Nov-23Payment of Exercise 804$75.92$61,039.70(< 1%)
105.92K to 105.11K
13-Nov-23 6:21 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 10-Nov-23Option Exercise 1,912----2%
104.0K to 105.92K
26-Oct-23 5:56 PM
View: 
Telman Deborah H
EVP, Corporate Affairs & GC
Gilead Sciences Inc. (GILD) 25-Oct-23Option Exercise 514----8%
6.49K to 7.0K
26-Oct-23 5:56 PM
View: 
Telman Deborah H
EVP, Corporate Affairs & GC
Gilead Sciences Inc. (GILD) 25-Oct-23Payment of Exercise 243$78.39$19,048.80(3%)
7.0K to 6.76K
18-Oct-23 4:31 PM
View: 
Dickinson Andrew D
Chief Financial Officer
Gilead Sciences Inc. (GILD) 17-Oct-23Private Sale (Planned) 5,000$80.00$400,017.00(5%)
109.0K to 104.0K
13-Sep-23 6:50 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 12-Sep-23Private Sale (Planned) 1,501$76.99$115,562.00(2%)
71.63K to 70.13K
11-Sep-23 8:19 PM
View: 
Parsey Merdad
Chief Medical Officer
Gilead Sciences Inc. (GILD) 10-Sep-23Payment of Exercise 1,278$76.00$97,128.00(2%)
72.91K to 71.63K
11-Sep-23 8:44 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 10-Sep-23Payment of Exercise 1,256$76.00$95,456.00(1%)
90.74K to 89.49K
11-Sep-23 8:44 PM
View: 
Mercier Johanna
Chief Commercial Officer
Gilead Sciences Inc. (GILD) 10-Sep-23Option Exercise 2,730----3%
88.01K to 90.74K
11-Sep-23 8:37 PM
View: 
Patterson Sandra
SVP, Controllership
Gilead Sciences Inc. (GILD) 10-Sep-23Payment of Exercise 149$76.00$11,324.00(< 1%)
30.27K to 30.12K
11-Sep-23 8:37 PM
View: 
Patterson Sandra
SVP, Controllership
Gilead Sciences Inc. (GILD) 10-Sep-23Option Exercise 519----2%
29.75K to 30.27K
11-Sep-23 8:11 PM
View: 
O'Day Daniel Patrick
Chairman & CEO
Director
Gilead Sciences Inc. (GILD) 10-Sep-23Option Exercise 7,348----2%
379.7K to 387.05K